GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » Enterprise Value

Epigenomics AG (Epigenomics AG) Enterprise Value : $-2.07 Mil (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Epigenomics AG's Enterprise Value is $-2.07 Mil. Epigenomics AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.25 Mil. Therefore, Epigenomics AG's EV-to-EBIT ratio for today is 0.12.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Epigenomics AG's Enterprise Value is $-2.07 Mil. Epigenomics AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-14.88 Mil. Therefore, Epigenomics AG's EV-to-EBITDA ratio for today is 0.14.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Epigenomics AG's Enterprise Value is $-2.07 Mil. Epigenomics AG's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.47 Mil. Therefore, Epigenomics AG's EV-to-Revenue ratio for today is -4.42.


Epigenomics AG Enterprise Value Historical Data

The historical data trend for Epigenomics AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Enterprise Value Chart

Epigenomics AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.45 58.03 21.05 -14.60 -2.54

Epigenomics AG Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.67 -8.94 -2.54 -3.98 -0.41

Competitive Comparison of Epigenomics AG's Enterprise Value

For the Diagnostics & Research subindustry, Epigenomics AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's Enterprise Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Enterprise Value falls into.



Epigenomics AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Epigenomics AG's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Epigenomics AG's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigenomics AG  (OTCPK:EPGNF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Epigenomics AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-2.070/-17.252
=0.12

Epigenomics AG's current Enterprise Value is $-2.07 Mil.
Epigenomics AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.25 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Epigenomics AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-2.070/-14.881
=0.14

Epigenomics AG's current Enterprise Value is $-2.07 Mil.
Epigenomics AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.88 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Epigenomics AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-2.070/0.468
=-4.42

Epigenomics AG's current Enterprise Value is $-2.07 Mil.
Epigenomics AG's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigenomics AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (Epigenomics AG) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines